We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
AUM
$336M
AUM Growth
+$14.4M
Cap. Flow
-$10M
Cap. Flow %
-2.98%
Top 10 Hldgs %
55.65%
Holding
52
New
7
Increased
17
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$11.7M
2
CMCSA icon
Comcast
CMCSA
+$8.1M
3
GSK icon
GSK
GSK
+$6.99M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$5.45M
5
CG icon
Carlyle Group
CG
+$3.57M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$15.1M
2
VST icon
Vistra
VST
+$9.23M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.41M
4
VVV icon
Valvoline
VVV
+$5.5M
5
ARES icon
Ares Management
ARES
+$5.41M

Sector Composition

Rank Sector Weight
1 Financials 53.11%
2 Healthcare 15.91%
3 Real Estate 9.15%
4 Consumer Staples 5.81%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEN icon
26
Gen Digital
GEN
$17.5B
$4.1M 1.22%
191,217
-8,783
-4% -$194K
CG icon
27
Carlyle Group
CG
$17.2B
$3.73M 1.11%
+125,000
New +$3.57M
CCAP icon
28
Crescent Capital BDC
CCAP
$434M
$3.19M 0.95%
250,000
+10,000
+4% +$136K
ET icon
29
Energy Transfer Partners
ET
$69.3B
$2.67M 0.8%
225,000
OLN icon
30
Olin
OLN
$2.12B
$2.65M 0.79%
50,000
-15,000
-23% -$796K
GBDC icon
31
Golub Capital BDC
GBDC
$3.42B
$2.63M 0.78%
200,000
+115,000
+135% +$1.52M
BIG
32
DELISTED
Big Lots, Inc.
BIG
$2.57M 0.77%
175,000
+75,000
+75% +$1.29M
OVV icon
33
Ovintiv
OVV
$16.4B
$2.54M 0.75%
50,000
-75,000
-60% -$3.92M
KSS icon
34
Kohl's
KSS
$2.19B
$2.52M 0.75%
100,000
STLA icon
35
Stellantis
STLA
$20.8B
$2.13M 0.63%
150,000
ARCC icon
36
Ares Capital
ARCC
$14.4B
$1.39M 0.41%
75,000
-147,887
-66% -$2.78M
PRGO icon
37
Perrigo
PRGO
$1.78B
$852K 0.25%
+25,000
New +$881K
EQT icon
38
EQT Corp
EQT
$32.3B
$846K 0.25%
25,000
+15,000
+150% +$602K
GPMT
39
Granite Point Mortgage Trust
GPMT
$61.2M
$804K 0.24%
+150,000
New +$974K
PLYM
40
DELISTED
Plymouth Industrial REIT
PLYM
$575K 0.17%
+30,000
New +$568K
RRGB icon
41
Red Robin
RRGB
$152M
$502K 0.15%
90,000
-115,085
-56% -$857K
SAM icon
42
Boston Beer
SAM
$1.92B
$494K 0.15%
1,500
+500
+50% +$181K
WHG icon
43
Westwood Holdings Group
WHG
$190M
$112K 0.03%
+10,100
New +$106K
CGBD icon
44
Carlyle Secured Lending
CGBD
$758M
-85,718
Closed -$981K
EAT icon
45
Brinker International
EAT
$9.66B
-13,333
Closed -$333K
MRK icon
46
Merck
MRK
$318B
-175,652
Closed -$15.1M
NEM icon
47
Newmont
NEM
$119B
-50,000
Closed -$2.1M
SAH icon
48
Sonic Automotive
SAH
$2.61B
-4,632
Closed -$201K
SLRC icon
49
SLR Investment Corp
SLRC
$715M
-193,689
Closed -$2.39M
TMUS icon
50
T-Mobile US
TMUS
$190B
-20,000
Closed -$2.68M

Similar funds

Callodine Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Callodine Capital Management held 52 positions worth $336M, up 4.5% from $322M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Callodine Capital Management's Q4 2022 filing shows 7 new, 17 increased, 14 reduced and 9 closed positions. Its largest new stake was Comcast: 245,000 shares worth $8.57M. The largest sale was Merck, an estimated $15.1M.

By sector, the portfolio is most concentrated in Financials at 53% of assets, down from 54% a quarter earlier, followed by Healthcare and Real Estate.

  • Callodine Capital Management's largest Q4 2022 buy was Comcast: 245,000 shares worth $8.57M.
  • Callodine Capital Management added most to Crown Castle in Q4 2022, an estimated $11.7M increase.
  • Callodine Capital Management's biggest Q4 2022 reduction was Vistra, cutting an estimated $9.23M.
  • Callodine Capital Management fully exited Merck in Q4 2022, selling an estimated $15.1M.
  • Callodine Capital Management's ten largest holdings make up 56% of its $336M portfolio in Q4 2022.
  • Callodine Capital Management opened 7 new positions and closed 9 in Q4 2022.
  • Callodine Capital Management's portfolio value rose 4.5% quarter-over-quarter to $336M.

Based on Callodine Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.